scholarly article | Q13442814 |
P356 | DOI | 10.4088/JCP.V67N0514 |
P50 | author | Roy H. Perlis | Q88592183 |
P2093 | author name string | Paul E. Keck | |
Daniel Y. Lin | |||
Doug J. Williamson | |||
Mauricio F. Tohen | |||
Michael G. Case | |||
Sara A. Corya | |||
P433 | issue | 05 | |
P921 | main subject | bipolar depression | Q56014658 |
P304 | page(s) | 798-806 | |
P577 | publication date | 2006-05-15 | |
P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
P1476 | title | A 24-Week Open-Label Extension Study of Olanzapine-Fluoxetine Combination and Olanzapine Monotherapy in the Treatment of Bipolar Depression | |
P478 | volume | 67 |
Q34475987 | Antipsychotics as antidepressants |
Q38003196 | Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder |
Q22241210 | Bipolar Disorder: An Update |
Q38808576 | Bipolar depression: Managing patients with second generation antipsychotics |
Q38109591 | Clinical issues in use of atypical antipsychotics for depressed patients |
Q37737291 | Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression |
Q34515834 | LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY |
Q47623090 | Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders |
Q38297863 | Managing the side effects associated with commonly used treatments for bipolar depression |
Q43211028 | Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial |
Q37256691 | Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility |
Q38072081 | Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression |
Q92001769 | Recent advances in the biological treatment of mood disorders |
Q34218568 | Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis |
Q34616633 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression |
Q34649187 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder |
Q37852818 | Treatment strategies for dosing the second generation antipsychotics. |
Q37078931 | Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor |
Search more.